Hampshire, UK. December 10th 2015

PRESS RELEASE


NEW PRODUCT LAUNCH - EVOLVE

Hampshire, UK. -Medicom Healthcare today announced the launch of EVOLVE®

Simon Martin, CEO, Medicom Healthcare said, “The launch of Evolve® Hypromellose and Evolve® Carmellose is the first step of our journey to provide preservative free eye care for everyone.”

About Dry Eye Disease

Dry eye is a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface. It is accompanied by increased osmolarity of the tear film and inflammation of the ocular surface.1

Dry eye may be exacerbated by issues such as reduced blink rate caused by computer use and environmental factors such as low humidity, wind, and sunlight.

Approximately 50 million adults in the European Union live with symptoms of dry eye disease,2 which typically include eye dryness, overall eye discomfort, stinging, burning, a gritty feeling, and may include episodes of blurred vision. The main drivers of dry eye are age, environment and lifestyle.

Dry eye is diagnosed based on patient-reported symptoms, such as eye dryness, overall eye discomfort, stinging, burning, a gritty feeling and episodes of blurred vision as well as signs, which can be objectively measured by an eye care professional to determine the presence of dry eye disease.

Medicom Healthcare’s Commitment to Ophthalmics

In August 2007, Medicom Healthcare established its Ophthalmic Business Unit, solidifying its commitment to growing in this therapeutic area.

Medicom Healthcare’s growth in ophthalmics has been driven by a combination of strategic product development and organic growth. Committed to growing its reputation as a leading Eye Care company, Medicom Healthcare is focused on continuing to expand its portfolio to include treatment options for Glaucoma, Allergy, Infection and Inflamation.

Since 2007, Medicom Healthcare has developed and brought to market 25 products in more than 15 countries. In the development pipeline, Medicom Healthcare has candidates in the therapeutic areas of Dry Eye, Glaucoma, Infection, Inflammation and Allergy with particular emphasis on expanding the Evolve® Multi-dose Preservative Free franchise.

About Evolve®

Evolve® is an innovative technology that delivers a preservative free, sterile eye drop from a multi-dose container. It is generally agreed that the elimination of preservatives in eye care products provides patients better therapy.

Medicom Healthcare has today launched two products in the area of Dry Eye with two further products set to launch in Q1 2016.

Further developments in Glaucoma, Allergy, Infection and Inflammation are under way.

About Medicom Healthcare

Medicom Healthcare is a privately owned speciality pharmaceutical company based in Hampshire, UK. Medicom Healthcare was founded in 2007 and has developed and brought to market 25 products that are available in more than 15 countries.



NOTES:

1 DEWS (2007) 2007 report of the International Dry Eye Workshop (DEWS). Ocular Surface5 (2), 65-204.

2 Data In House

www.medicomhealthcare.com


FOR FURTHER INFORMATION PLEASE CONTACT:

Commercial:

Christian Martin

christian.martin@medicomhealthcare.com
Mobile: +44 (0) 7584 671848

Financial:


Headquarters:

Unit 5, Concorde Close, Fareham, PO15 5RT

Telephone

+44 (0) 1489 574119

Fax

+44 (0) 1489 564009

Registered Address: 235 Hunts Pond Road, Titchfield Common, Fareham, Hampshire, PO14 4PJ


Evolve® is a registered trademark which is fully owned by Medicom Healthcare

Press Releases